MBX 2109

DRUG2 trials

Sponsors

MBX Biosciences

Conditions

HypoparathyroidismRenal Impairment

Phase 1

Safety and Pharmacokinetics Study of MBX 2109 in Adult Subjects With Normal and Impaired Renal Function

CompletedNCT06496217

MBX BiosciencesRenal Impairment

Start: 2024-06-13End: 2025-09-04Updated: 2025-10-28

Phase 2

Safety, Pharmacokinetics and Efficacy of MBX 2109 in Patients With Hypoparathyroidism

CompletedNCT06465108

MBX BiosciencesHypoparathyroidism

Start: 2024-08-08End: 2025-06-04Updated: 2026-03-20

Related Papers

MBX 2109, A Once-Weekly Parathyroid Hormone Replacement Therapy Prodrug: Phase 1, First-In-Human, Randomized Trial

The Journal of Clinical Endocrinology & Metabolism2024-11-229 citations